PLASMA CYSTATIN C LEVEL IS A PROGNOSTIC MARKER OF MORBIDITY AND MORTALITY IN HOSPITALIZED DECOMPENSATED CIRRHOTIC PATIENTS

被引：0
|
作者：
Limprukkasem, Tanabute
Pornthisarn, Bubpha
Vilaichone, Ratha-Korn
Chonprasertsuk, Soonthorn
Bhanthumkomol, Patommatat
Kanokwanvimol, Amornnivit
Chotivitayatarakorn, Peranart
Tantiyavarong, Pichaya
Siramolpiwat, Sith
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1518
引用
收藏
页码：S1350 / S1351
页数：2
相关论文
共 50 条
  • [41] Cystatin C: an emerging marker for pre-timely mortality
    Hansson, Lars-Olof
    JOURNAL OF INTERNAL MEDICINE, 2010, 268 (02) : 106 - 108
  • [42] Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis
    Wu, JianPing
    Wu, QianXia
    Wu, MinYi
    Mao, WeiLin
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [43] PROGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN HOSPITALIZED DECOMPENSATED CIRRHOTIC PATIENTS WITH AND WITHOUT ACUTE-ON-CHRONIC LIVER FAILURE
    Chiriac, Stefan A.
    Stanciu, Carol
    Cojocariu, Camelia
    Sfarti, Catalin
    Singeap, Ana Maria
    Girleanu, Irina
    Cuciureanu, Tudor
    Trifan, Anca
    GASTROENTEROLOGY, 2019, 156 (06) : S565 - S566
  • [44] Cystatin c as marker of cardiorenal syndrome in patients hospitalized with acute heart failure and normal renal function. validation of a cystatin c cutoff value
    Constantin, I.
    Del Castillo, S. L.
    Varela, C. F.
    Guzzetti, E.
    Citterio, P. L.
    Romeo, F. J.
    Greloni, G.
    Diez, G. J. Rosa
    Pizarro, R.
    Belziti, C. A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 720 - 720
  • [45] Plasma Mitochondrial DNA Level is a Prognostic Marker in Peritoneal Dialysis Patients
    Szeto, Cheuk-Chun
    Lai, Ka-Bik
    Chow, Kai-Ming
    Kwan, Bonnie Ching-Ha
    Cheng, Phyllis Mei-Shan
    Kwong, Vickie Wai-Ki
    Choy, Agnes Shin-Man
    Leung, Chi-Bon
    Li, Philip Kam-Tao
    KIDNEY & BLOOD PRESSURE RESEARCH, 2016, 41 (04): : 402 - 412
  • [46] Prognostic value of in-hospital change in cystatin C in patients with acutely decompensated heart failure and renal dysfunction
    Rafouli-Stergiou, Pinelopi
    Parissis, John
    Farmakis, Dimitrios
    Bistola, Vassiliki
    Nikolaou, Maria
    Vasiliadis, Konstantinos
    Ikonomidis, Ignatios
    Kremastinos, Dimitrios
    Lekakis, John
    Filippatos, Gerasimos
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 182 : 74 - 76
  • [47] Cystatin C: A prognostic marker after myocardial infarction in patients without chronic kidney disease
    Abid, Leila
    Charfeddine, Salma
    Kammoun, Samir
    Turki, Mouna
    Ayedi, Fatma
    JOURNAL OF THE SAUDI HEART ASSOCIATION, 2016, 28 (03) : 144 - 151
  • [48] Serum cystatin C concentrations were elevated in cirrhotic patients
    Ulusoy, C.
    Tiftikci, A.
    Imeryuz, N.
    Celikel, C.
    Haklar, G.
    FEBS JOURNAL, 2006, 273 : 341 - 342
  • [49] CYSTATIN C: A BETTER MARKER THAN SERUM CREATININE FOR > STAGE 2 ACUTE KIDNEY INJURY (AKI) AND WAITLIST MORTALITY (WLM) AMONG DECOMPENSATED CIRRHOSIS PATIENTS
    Cullaro, Giuseppe
    Patidar, Kavish R.
    Debakey, Michael E.
    Allegretti, Andrew
    Lai, Jennifer C.
    HEPATOLOGY, 2023, 78 : S264 - S265
  • [50] MORBIDITY AND MORTALITY AFTER OPERATION IN NONBLEEDING CIRRHOTIC-PATIENTS
    DOBERNECK, RC
    STERLING, WA
    ALLISON, DC
    AMERICAN JOURNAL OF SURGERY, 1983, 146 (03): : 306 - 309
12345